JAMA Author Interviews podcast

#Science #Medicine #Fitness #American Medical Association #JAMA Network #Research #Authors #Interviews #Journalism

43:43

Wyatt Flores is a 23-year-old singer-songwriter from Stillwater, Oklahoma, who’s making a name for himself in the Red Dirt music scene, building on the musical legacy of his home state. He grew up on a ranch in a working-class family where he was surrounded by musicians, often hearing them play cowboy songs around a campfire. His father, a drummer, built him a stage in the backyard when he recognized his talent, and his Uncle Bobby taught him how to play guitar. Now Wyatt is playing in front of thousands of fans, singing at the Grand Ole Opry, and writing songs that are winning audiences with their honesty, heart, and vulnerability. His debut album, Welcome to the Plains, explores the rough—and sometimes violent—side of growing up in rural Oklahoma, but it also shows a talent for storytelling and a wry sense of humor. Sid talks to Wyatt about why he’s so happy to be back in Stillwater after a couple of years in Nashville, the mental health struggles he’s openly shared with his fans, the family member he wants to have on his podcast, and why his favorite food is a breakfast burrito. Learn more about your ad choices. Visit podcastchoices.com/adchoices…

JAMA Author Interviews

Поширити

Головна серій•Feed

Interviews with leading researchers and thinkers in health care about practice-changing research, innovations, and the most pressing issues facing medicine and health care today from JAMA, the Journal of the American Medical Association.

854 епізодів

JAMA Author Interviews

0-10 subscribers

updated рік тому

Поширити

Головна серій•Feed

854 епізодів

#Science #Medicine #Fitness #American Medical Association #JAMA Network #Research #Authors #Interviews #Journalism

Усі епізоди

JAMA Author Interviews

1
Life Support and Outcomes in Patients Admitted to Intensive Care Units 19:01

10 weeks тому19:01

19:01

Nationwide data are unavailable regarding changes in intensive care unit (ICU) outcomes over the past 10 years, limiting understanding of practice changes. Authors Emily Moin, MD, MBE, and Scott D. Halpern, MD, PhD, MBE, of the University of Pennsylvania join JAMA Associate Editor Christopher W. Seymour, MD, MSc, to discuss how ICU care and outcomes have changed in the US over the past decade. Related Content: Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units…

JAMA Author Interviews

1
Increases in Invasive Group A Streptococcal Infections 13:53

11 weeks тому13:53

13:53

The incidence of invasive group A streptococcal infections has risen in the US. Similar observations have been reported in other parts of the world. Authors Joshua Osowicki, MBBS, PhD, of Murdoch Children’s Research Institute and Theresa L. Lamagni, MSc, PhD, of the United Kingdom Health Security Agency join JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the public health challenge posed by group A strep. Related Content: Invasive Group A Streptococcal Disease in the US Invasive Group A Streptococcal Infections in 10 US States…

JAMA Author Interviews

1
Preventive Health Care Among Adults Eligible for Lung Cancer Screening 9:09

12 weeks тому9:09

9:09

Less than 20% of patients eligible for lung cancer screening get screened in the US. A recent study examined whether adults eligible for lung cancer screening engage in screening for other types of cancer. Coauthor Chi-Fu Jeffrey Yang, MD, of Harvard Medical School joins JAMA Deputy Editor Tracy Lieu, MD, to discuss. Related Content: Preventive Health Care Use Among Adults Eligible for Lung Cancer Screening in the US…

JAMA Author Interviews

1
Cardiac Arrests During Long-Distance Running: What’s Changed? 15:22

12 weeks тому15:22

15:22

Despite increased participation in US long-distance running races, cardiac arrest incidence remains stable. Authors Jonathan Kim, MD, MSc, of Emory University, and Aaron Baggish, MD, of the University of Lausanne Switzerland, discuss the RACER 2 study and compare results with initial findings published in the RACER 1 study from 13 years ago, with JAMA Associate Editor Gregory Marcus, MD, MAS. Related Content: Cardiac Arrest During Long-Distance Running Races…

JAMA Author Interviews

1
Inhaled Sedation With Sevoflurane for Acute Respiratory Distress Syndrome (ARDS) 18:08

14 weeks тому18:08

18:08

ARDS, which is characterized by hypoxemic respiratory failure and inflammatory injury to the lungs, has a mortality rate of 30% to 40%. Balasubramanian Venkatesh, MD, of the George Institute for Global Health joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the effects of inhaled sedation with sevoflurane for patients with moderate to severe ARDS. Related Content: Sevoflurane Sedation in Acute Respiratory Distress Syndrome Inhaled Sedation in Acute Respiratory Distress Syndrome…

JAMA Author Interviews

1
New FDA Pulse Oximetry Guidance: Strengths and Weaknesses 16:50

16 weeks тому16:50

16:50

The US Food and Drug Administration (FDA) issued new draft regulatory guidance for pulse oximeters related to skin pigment. The guidance is a step forward but it may have unintended consequences. Authors Michael Lipnick, MD, and Philip Bicker, MD, PhD, professors of anesthesia at University of California, San Francisco, discuss this and more with JAMA Executive Editor Gregory Curfman, MD. Related Content: Pulse Oximetry and Skin Pigmentation—New Guidance From the FDA Adherence to FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals, 1996-2024 Addressing Racial and Ethnic Bias in Pulse Oximeters—A Wicked Problem Evaluating the Accuracy of Pulse Oximetry in Children According to Race…

JAMA Author Interviews

1
Combining CAC Score With Treatment on Plaque Progression in Familial Coronary Artery Disease 10:23

16 weeks тому10:23

10:23

The CAUGHT-CAD randomized clinical trial sought to determine whether a CAC score-informed strategy could slow the progression of coronary plaque volume. Author Thomas H. Marwick of the Baker Heart & Diabetes Institute joins JAMA Associate Editor Pradeep Natarajan to discuss "Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease." Related Content: Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease Cardiac CT Calcium Score Coronary Artery Calcium Testing—Too Early, Too Late, Too Often Filling the Evidence Gaps Toward a Coronary Artery Calcium-Guided Primary Prevention Strategy…

JAMA Author Interviews

1
Evaluating Treatments for Amyotrophic Lateral Sclerosis 22:34

18 weeks тому22:34

22:34

The HEALEY ALS platform is an innovative first attempt at platform trials in ALS, looking to slow ALS disease progression. Author Sabrina Paganoni, MD, PhD, of Massachusetts General Hospital and Harvard Medical School, discusses results of the first 4 drug regimens from this platform trial and how this study design makes efficient use of resources, with JAMA Deputy Editor Christopher Muth, MD. Related Content: Platform Clinical Trials for the Efficient Evaluation of Multiple Treatments Pridopidine in Amyotrophic Lateral Sclerosis Platform Trials in ALS Verdiperstat in Amyotrophic Lateral Sclerosis Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis CNM-Au8 in Amyotrophic Lateral Sclerosis…

JAMA Author Interviews

1
US Health Care Spending by Health Condition and County—What Drives Variation? 13:28

19 weeks тому13:28

13:28

Understanding health conditions with the most spending and variation across locations and over time is important for identifying trends, inequalities, and strategies for lowering health spending. Joseph Dieleman, PhD, of the University of Washington speaks with JAMA Associate Editor Karen Joynt Maddox, MD, MPH, about county-level variation in health care spending across the US. Related Content: Tracking US Health Care Spending by Health Condition and County…

JAMA Author Interviews

1
Supporting Children and Families in an Era With Abortion Restrictions 11:12

19 weeks тому11:12

11:12

Two recent studies published in JAMA provide evidence about the effects of state-level abortion restrictions on birth rates and infant mortality. Author Alyssa Bilinski, PhD, MSc, of Brown University School of Public Health joins JAMA Deputy Editor Tracy Lieu, MD, to discuss her related Editorial "Abortion May Be Controversial—Supporting Children and Families Need Not Be." Related Content: Abortion May Be Controversial—Supporting Children and Families Need Not Be…

JAMA Author Interviews

1
Evaluating Comprehensive Models–Challenges and Innovations in Dementia Care 17:50

21 weeks тому17:50

17:50

Contemporary models of dementia care are multidisciplinary and aim to bridge medical and social services. Julie P. W. Bynum, MD, MPH, of the University of Michigan speaks with JAMA Deputy Editor Christopher C. Muth, MD, about 2 trials—the D-CARE and IN-PEACE trials—that evaluated care models to support people diagnosed with dementia and their caregivers. Related Content: Challenges and Innovations in Dementia Care—Evaluating Comprehensive Models Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers Palliative Care Program for Community-Dwelling Individuals With Dementia and Caregivers…

JAMA Author Interviews

1
Intra-Arterial Thrombolytics Following Thrombectomy for Ischemic Stroke 11:07

23 weeks тому11:07

11:07

Two new trials published in JAMA evaluate the efficacy of periprocedural intra-arterial thrombolytics after successful endovascular thrombectomy for patients with acute ischemic stroke. Diederik Dippel, MD, PhD, of Erasmus University Medical Center discusses this and more with JAMA Deputy Editor Christopher C. Muth, MD. Related Content: Intra-Arterial Thrombolytics During Thrombectomy for Ischemic Stroke—End of the Story or a New Beginning? Intra-Arterial Tenecteplase Following Endovascular Reperfusion for Large Vessel Occlusion Acute Ischemic Stroke Intra-Arterial Urokinase After Endovascular Reperfusion for Acute Ischemic Stroke…

JAMA Author Interviews

1
Impact of Private Equity Acquisition on Patient Care Experience in US Hospitals 13:09

24 weeks тому13:09

13:09

Private equity acquisitions of health care facilities have rapidly increased over the past decade. However, little is known about the effects of these acquisitions on patient experience. Author Rishi K. Wadhera, MD, MPP, MPhil, of Harvard Medical School discusses this topic with JAMA Associate Editor Karen Joynt Maddox, MD, MPH. Related Content: Changes in Patient Care Experience After Private Equity Acquisition of US Hospitals…

JAMA Author Interviews

1
Asthma Endotypes Based on Nasal Epithelial Biopsies in School-Aged Youth 11:33

25 weeks тому11:33

11:33

Certain CD4+ T-cell subtypes play a role in asthma. Characterizing asthma endotypes in diverse groups is important to help develop effective therapies for youth with asthma. Author Juan C. Celedon, MD, DrPH, University of Pittsburgh, Department of Pediatrics, discusses this and more with JAMA Deputy Editor Kristin L. Walter, MD, MS. Related Content: Transcriptomic Profiles in Nasal Epithelium and Asthma Endotypes in Youth…

JAMA Author Interviews

1
Dental Benefits and Medicare Advantage Plans 11:20

26 weeks тому11:20

11:20

Most Medicare Advantage (MA) plans offer dental care coverage as a supplemental benefit. However,few beneficiaries are enrolled in an MA plan that provides comprehensive dental benefits. Lisa Simon, MD, DMD, discusses this and more with JAMA Deputy Editor Kristin L. Walter, MD, MS. Related Content: Availability of Dental Benefits Within Medicare Advantage Plans by Enrollment and County…

JAMA Author Interviews

1
2024 Update on Long COVID Classification and Symptom List 12:18

27 weeks тому12:18

12:18

Long COVID is now defined as a heterogeneous, infection-associated chronic condition present for at least 3 months after SARS-CoV-2 infection. Author Leora Horwitz, MD, MHS, of NYU Grossman School of Medicine joins JAMA Executive Editor Gregory Curfman, MD, to discuss the JAMA article "2024 Update of the RECOVER-Adult Long COVID Research Index." Related Content: 2024 Update of the RECOVER-Adult Long COVID Research Index Characterizing Long COVID in Children and Adolescents…

JAMA Author Interviews

1
Camrelizumab vs Placebo With Chemotherapy as Neoadjuvant Treatment in Triple-Negative Breast Cancer 15:14

28 weeks тому15:14

15:14

Triple-negative breast cancer accounts for around 15% of breast cancers. Zhi-Ming Shao, MD, of Fudon University, joins JAMA Oncology Editor in Chief and JAMA Deputy Editor Nora Disis, MD, to discuss "Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients with Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial." Related Content: Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer…

JAMA Author Interviews

1
HIV Treatment and Prevention: Updated Recommendations 15:00

29 weeks тому15:00

15:00

New antiretroviral drugs and formulations continue to become available for the prevention and management of HIV infection. Author Rajesh T. Gandhi, MD, joins JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss these new approaches for HIV. Related Content: Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel Advances in Treatment and Prevention of HIV…

JAMA Author Interviews

1
The Impacts of Severe Maternal Morbidity 13:25

30 weeks тому13:25

13:25

A new JAMA study examines the association between severe maternal morbidity in a first birth and the probability of a subsequent birth. Authors Neda Razaz, PhD, and Eleni Tsamantioti, MD, MMedSc, both from the Karolinska Institute in Sweden, discuss this and more with JAMA Associate Editor Melissa A. Simon, MD, MPH. Related Content: Association of Severe Maternal Morbidity With Subsequent Birth Severe Maternal Morbidity and Subsequent Birth—Understanding and Informing a Woman’s Choice…

JAMA Author Interviews

1
Zerlasiran, a Small-Interfering RNA That Targets Lipoprotein(a) 14:21

31 weeks тому14:21

14:21

Elevated lipoprotein(a) levels increase the risk of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Cleveland Clinic’s Steven E. Nissen, MD, speaks with JAMA Executive Editor Gregory Curfman, MD, about how zerlasiran produced more than 80% reductions in time-averaged lipoprotein(a) concentration. Related Content: Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)…

JAMA Author Interviews

1
Intratracheal Budesonide for Extremely Preterm Infants 8:27

32 weeks тому8:27

8:27

Preterm birth is the greatest cause of neonatal mortality and morbidity, with infants born extremely preterm at highest risk. Author Brett J. Manley, PhD, the Royal Women’s Hospital, Melbourne, Australia, discusses a new study of the effect of intratracheal corticosteroid administration on survival free of bronchopulmonary dysplasia in preterm infants, with JAMA Deputy Editor Tracy A. Lieu, MD, MPH. Related Content: Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants…

JAMA Author Interviews

1
Digital Health Behavior Intervention to Prevent Childhood Obesity 13:05

33 weeks тому13:05

13:05

Preventing obesity in early childhood is challenging for clinicians and families. Authors Eliana M. Perrin, MD, MPH, of Johns Hopkins University, and William J. Heerman, MD, MPH, of Vanderbilt University, join JAMA Deputy Editor Tracy Lieu, MD, to discuss "A Digital Health Behavior Intervention to Prevent Childhood Obesity: The Greenlight Plus Randomized Clinical Trial." Related Content: A Digital Health Behavior Intervention to Prevent Childhood Obesity…

JAMA Author Interviews

1
Drug Shortages After Supply Chain Issues in the US vs Canada 11:42

34 weeks тому11:42

11:42

A new study published in JAMA found that drug-related supply chain issue reports were 40% less likely to result in meaningful drug shortages in Canada compared with the US. Authors Kate Suda, PharmD, MS, of University of Pittsburgh School of Medicine, and Mina Tadrous, PharmD, PhD, of University of Toronto, discuss this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS. Related Content: Differences in Drug Shortages in the US and Canada Understanding Drug Supply Shortages in the US and Canada…

JAMA Author Interviews

1
Advanced Birth Centers Raise Safety Concerns for Obstetric Care 10:12

35 weeks тому10:12

10:12

In the US, childbirth typically occurs in hospitals or accredited birth centers. President of the American College of Obstetricians and Gynecologists Stella Marie Dantas, MD, speaks with JAMA Deputy Editor Linda Brubaker, MD, MS, about newly proposed advanced birth centers that would permit higher-risk births, with concerns for patient safety and rural obstetric care access. Related Content: Advanced Birth Centers and the Effect on Maternity Care…

JAMA Author Interviews

1
Declaration of Helsinki Addresses New Ethical Challenges 15:08

35 weeks тому15:08

15:08

The Declaration of Helsinki originated in 1964, developed by the World Medical Association (WMA). Process Chair Jack S. Resneck Jr, MD, discusses the 2024 updates to the Declaration of Helsinki with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Revisions to the Declaration of Helsinki on Its 60th Anniversary World Medical Association Declaration of Helsinki Making the Ethical Oversight of All Clinical Trials Fit for Purpose The Revised Declaration of Helsinki—Considerations for the Future of Artificial Intelligence in Health and Medical Research Revisiting the Declaration of Helsinki—A Patient-Centered Perspective Future-Proofing Research Ethics—Key Revisions of the Declaration of Helsinki 2024 The Revision of the Declaration of Helsinki Viewed From the Americas—Paving the Way to Better Research Declaration of Helsinki—Revisions for the 21st Century Facilitating Efficient and Ethical Trials at the Intersection of Research and Clinical Care The 2024 Revision to the Declaration of Helsinki…

JAMA Author Interviews

1
JAMA Critical Care Research at ESICM Congress 2024 15:37

37 weeks тому15:37

15:37

Transfusion strategy for patients with acute brain injury, telehealth care, acute kidney injury after cardiac surgery, and weaning ventilatory support are the topics of 4 trials published in JAMA and presented at the 2024 European Society of Intensive Care Medicine meeting. JAMA Associate Editor Christopher Seymour, MD, MSc, joins Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss. Related Content: Shifting Balance of the Risk-Benefit of Restrictive Transfusion Strategies in Neurocritically Ill Patients—Is Less Still More? Evaluating Complex Technological Innovations in Critical Care—Current Challenges and Future Directions Impact of Adsorptive Blood Purification on Kidney Outcomes Ventilator Weaning Strategies—Managing Interaction Between Randomized Treatments Restrictive vs Liberal Transfusion Strategy in Patients With Acute Brain Injury Effect of Tele-ICU on Clinical Outcomes of Critically Ill Patients Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery Frequency of Screening and Spontaneous Breathing Trial Techniques…

JAMA Author Interviews

1
Fecal Immunochemical Test (FIT) and Helicobacter pylori Stool Antigen Co-Testing for Gastric Cancer 11:35

38 weeks тому11:35

11:35

Gastric cancer is a leading cause of cancer death globally. Chronic H pylori infection is the primary cause of gastric cancer, responsible for at least 80% of the new cases. Constanza Camargo, PhD, of the National Cancer Institute joins JAMA Associate Editor John M. Inadomi, MD, to discuss co-testing with FIT and H pylori stool antigen to help prevent gastric cancer. Related Content: Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing Screening for Helicobacter pylori to Prevent Gastric Cancer…

JAMA Author Interviews

1
Preventing Fever in Patients With Acute Vascular Brain Injury 10:37

39 weeks тому10:37

10:37

Fever is associated with worse outcomes in patients with stroke, but whether preventing fever improves outcomes is unclear. David M. Greer, MD, MA, speaks with JAMA Associate Editor Jeffrey L. Saver, MD, about fever prevention in patients with acute stroke and its impact on functional outcomes. Related Content: Fever Prevention in Patients With Acute Vascular Brain Injury Feasibility of Fever Prevention in Vascular Brain Injury…

JAMA Author Interviews

1
The Discovery of Glucagon-Like Peptide 1 (GLP-1) 11:45

40 weeks тому11:45

11:45

The 2024 Lasker–DeBakey Clinical Medical Research Award has been presented for the discovery of GLP-1 and its application to the treatment of obesity. Lasker winner Svetlana Mojsov, PhD, discusses her role in this innovative discovery and more with JAMA Senior Editor Anne Rentoumis Cappola, MD, ScM. Related Content: Chemistry Matters—From a Putative Peptide to Effective Treatments for Diabetes and Obesity Discovery of cGAS as a DNA-Sensing Enzyme That Triggers Inflammation GLP-1 for Treating Obesity—Origin, History, and Evolution AIDS in Africa—Impact of Research…

JAMA Author Interviews

1
Improving Access to Palliative Care for Patients With Cancer 11:53

41 weeks тому11:53